Ailing Zhong

497 total citations
29 papers, 355 citations indexed

About

Ailing Zhong is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Ailing Zhong has authored 29 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Surgery. Recurrent topics in Ailing Zhong's work include DNA Repair Mechanisms (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and CRISPR and Genetic Engineering (4 papers). Ailing Zhong is often cited by papers focused on DNA Repair Mechanisms (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and CRISPR and Genetic Engineering (4 papers). Ailing Zhong collaborates with scholars based in China, Japan and United States. Ailing Zhong's co-authors include Lin Guo, Renquan Lu, Yanchun Wang, Hongqin Zhang, Suhong Xie, Chien‐shan Cheng, Hui Zheng, Yiwen Yu, Miaomiao Chen and Ying Tong and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Ailing Zhong

27 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ailing Zhong China 13 192 124 104 59 42 29 355
Yi‐Fang Tsai Taiwan 13 219 1.1× 173 1.4× 123 1.2× 94 1.6× 40 1.0× 47 473
Yukari Ishiguro Japan 12 148 0.8× 138 1.1× 59 0.6× 91 1.5× 86 2.0× 19 364
Haiyun Zhao China 10 304 1.6× 103 0.8× 154 1.5× 51 0.9× 17 0.4× 13 423
Weiya Z. Wysham United States 12 222 1.2× 133 1.1× 137 1.3× 38 0.6× 55 1.3× 23 467
Mary‐Kate Malecek United States 5 203 1.1× 112 0.9× 100 1.0× 22 0.4× 58 1.4× 5 300
Eufemia Savino Italy 13 164 0.9× 161 1.3× 122 1.2× 51 0.9× 33 0.8× 17 430
Yanwei Ye China 10 181 0.9× 74 0.6× 93 0.9× 45 0.8× 29 0.7× 23 315

Countries citing papers authored by Ailing Zhong

Since Specialization
Citations

This map shows the geographic impact of Ailing Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailing Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailing Zhong more than expected).

Fields of papers citing papers by Ailing Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailing Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailing Zhong. The network helps show where Ailing Zhong may publish in the future.

Co-authorship network of co-authors of Ailing Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Ailing Zhong. A scholar is included among the top collaborators of Ailing Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailing Zhong. Ailing Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yejun, Ailing Zhong, Wenbin Ye, et al.. (2025). A fast, non-invasive auxiliary screening algorithm for lung cancer based on electronic nose system. Sensors and Actuators A Physical. 389. 116490–116490.
2.
Sun, Qiang, Wenjun Fan, Fang Liu, et al.. (2025). Melatonin ameliorates myocardial ischemia/reperfusion injury via regulating the ubiquitin-proteasome system. Life Sciences. 380. 123973–123973.
3.
Chen, Jing, Wenlong Hu, Junjie Zhang, et al.. (2024). Salvage surgery and conversion surgery for patients with nonsmall cell lung cancer: a narrative review. International Journal of Surgery. 111(1). 1032–1041. 1 indexed citations
4.
Zhong, Ailing, et al.. (2024). Suppression of NBS1 Upregulates CyclinB to Induce Olaparib Sensitivity in Ovarian Cancer. Technology in Cancer Research & Treatment. 23. 2223953973–2223953973. 2 indexed citations
5.
Wang, Ruifeng, et al.. (2023). Lung Transplantation for Pulmonary Arterial Hypertension: Optimized Referral and Listing Based on an Evolving Disease Concept. Journal of Cardiovascular Development and Disease. 10(8). 350–350. 2 indexed citations
6.
Zhang, Yan, et al.. (2023). Risk factors of aspiration occurrence with different feeding patterns in elderly intensive care unit patients: a cross-sectional study. Journal of Thoracic Disease. 15(5). 2585–2600. 2 indexed citations
7.
Que, Haiying, Weiqi Hong, Tianxia Lan, et al.. (2022). Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal Transduction and Targeted Therapy. 7(1). 399–399. 22 indexed citations
8.
Xu, Jing, Ailing Zhong, Chong Chen, Yu Liu, & Ting Niu. (2022). KMT2D Deficiency Promotes Myeloid Leukemias through Regulating Ribosome Biogenesis. Blood. 140(Supplement 1). 5855–5856. 1 indexed citations
10.
Zhong, Ailing, et al.. (2020). Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer. Frontiers in Oncology. 10. 520330–520330. 39 indexed citations
11.
Zheng, Hui, Ailing Zhong, Suhong Xie, et al.. (2019). Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression. Cancer Medicine. 8(2). 679–685. 21 indexed citations
12.
Lu, Renquan, Suhong Xie, Yanchun Wang, et al.. (2019). MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System. Frontiers in Oncology. 9. 1189–1189. 14 indexed citations
13.
Zhong, Ailing, Hui Zheng, Hongqin Zhang, et al.. (2019). MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway. Journal of Cancer. 10(10). 2276–2287. 9 indexed citations
14.
Zhong, Ailing, Wenjun Qin, Jing Han, et al.. (2019). Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients. Frontiers in Oncology. 9. 114–114. 14 indexed citations
15.
Zhang, Hongqin, Guihong Zhang, Ailing Zhong, et al.. (2018). Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Biochemical and Biophysical Research Communications. 507(1-4). 74–82. 41 indexed citations
16.
Zhong, Ailing, et al.. (2018). Metformin suppresses growth and adrenocorticotrophic hormone secretion in mouse pituitary corticotroph tumor AtT20 cells. Molecular and Cellular Endocrinology. 478. 53–61. 14 indexed citations
17.
Lu, Renquan, Yingchao Wang, Xiaofeng Xu, et al.. (2018). Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma. BMC Biochemistry. 19(1). 6–6. 2 indexed citations
18.
Zhang, Hongqin, Ailing Zhong, Miaomiao Chen, et al.. (2017). COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level. Biochemical and Biophysical Research Communications. 493(1). 85–93. 18 indexed citations
19.
Wang, Zhiming, et al.. (2016). Isolated double adrenocorticotropic hormone-secreting pituitary adenomas: A case report and review of the literature. Oncology Letters. 12(1). 585–590. 9 indexed citations
20.
Hu, Yanping, Ailing Zhong, & Xiaoming Yang. (2000). [Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer].. PubMed. 22(1). 30–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026